Exploring the microbiome in burn wounds using advanced sequencing techniques
Official title: Understanding the Burn Wound Microbiome: Comparing Traditional Wound Cultures to Next Generation Sequencing Technology
Run by The University of Texas Medical Branch, Galveston · NCT05275335 · Data updated 2026-11-12
This study is trying to see how the germs in burn wounds affect healing and recovery in adults with serious burns.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Galveston, Texas) |
| Status | Recruiting |
| Started | November 1, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT05275335 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with partial or full thickness burn wounds requiring surgical intervention.
✕Probably not a fit
Patients under 18 years of age or those whose burn wounds are limited to the genitalia and perineum may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This investigation aims to enhance our understanding of the microbiome present in burn wounds and its influence on treatment outcomes and complications. By comparing traditional wound cultures with next-generation sequencing technology, the study seeks to uncover the complex interactions between microbial colonization and wound healing processes. The research will involve adult patients with partial or full thickness burns who are undergoing operative intervention, allowing for the collection of relevant biospecimens. The findings could provide insights into how the microbiome affects infection rates and overall patient prognosis.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for burn patients by tailoring interventions based on microbiome profiles.
How similar studies have gone: While the exploration of the wound microbiome is a growing field, this specific approach using next-generation sequencing in burn wounds is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adult patients (18 years of age and greater) admitted to or consulted by the Acute Burn Surgery service with a diagnosis of a partial thickness or full thickness burn wound determined by the Acute Burn Surgery service to be appropriate for operative intervention. We will include patients 18 years of age and older of any gender, race, prior therapy, or pre-existing medical condition. We will also include subjects in special classes, including pregnant women and cognitively impaired persons. Exclusion Criteria: * Children (less than 18 years of age) will be excluded. Patients who do not undergo operative therapy or patients whose operative therapy does not involve tangential excision of burn wounds will also not be eligible for inclusion by virtue of not being able to provide appropriate biospecimens. Patients whose burn wounds are isolated to the genitalia and perineum will be excluded from the study. For patients who have multiple burn wounds including those to the genitalia and perineum, it should be noted that excised tissues from the genitalia and perineum are not eligible for inclusion to the Burn Wound Data/Bio-Repository. Finally, patients whose operative intervention results in less than a total of 4 grams of discarded tissue will be excluded due to insufficient specimen for proper tissue analysis. Any tissue allocated for pathology or that has already been physically discarded into a trash receptacle will not be eligible for inclusion in the Burn Wound Data/Bio-Repository. We will also exclude prisoners from this study.
Where it's running
-
University of Texas Medical Branch
Galveston, Texas, United States Recruiting
Study contacts
- Principal investigator: Steven E Wolf, MD — University of Texas
- Study coordinator: Steven E Wolf, MD
- Email: swolf@utmb.edu
- Phone: 12107870507
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Efferon LPS hemoadsorption for severe burns
This study tests whether adding Efferon LPS hemoadsorption to standard care can help burn patients with high illness scores see if their symptoms improve and prevent organ failure.
-
Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide
This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.
-
Wearable hip-robot training to improve walking after major lower-leg burns
This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.
-
Tilapia skin versus regular dressings for second- and third-degree burns
This trial will test whether tilapia fish skin dressings help people with second- or third-degree burns heal better than regular dressings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.